Hexagon Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19	Closed	-$688	–	1330
2025 Q1	$688	Sell	19 -74	-80%	-$2.68K	﹤0.01%	1603
2024 Q4	$3.91K	Buy	+93	New	+$3.91K	﹤0.01%	1256